Press "Enter" to skip to content

New patent for MC2 drug WYNZORA

1
Copyright © DrugPatentWatch. Originally published at New patent for MC2 drug WYNZORA

Annual Drug Patent Expirations for WYNZORA
Annual Drug Patent Expirations for WYNZORA

Wynzora is a drug marketed by MC2 and is included in one NDA.

The generic ingredient in WYNZORA is betamethasone dipropionate; calcipotriene. Additional details are available on the betamethasone dipropionate; calcipotriene profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for MC2 drug WYNZORA
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    Do NOT follow this link or you will be banned from the site!